S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
OTCMKTS:CMXC

Cell MedX Stock Forecast, Price & News

$0.17
0.00 (0.00%)
(As of 12/8/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.15
$0.17
50-Day Range
$0.11
$0.25
52-Week Range
$0.10
$0.43
Volume
21,094 shs
Average Volume
43,734 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive CMXC News and Ratings via Email

Sign-up to receive the latest news and ratings for Cell MedX and its competitors with MarketBeat's FREE daily newsletter.


Cell MedX logo

About Cell MedX

Cell MedX Corp. is a biotech company, which engages in the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness. Its products include microcurrent therapy and eBalance systems. The company was founded on March 19, 2010 and is headquartered in Carson City, NV.

Headlines

Cell MedX Corp. (OTCMKTS:CMXC) Sees Large Growth in Short Interest
November 27, 2021 |  americanbankingnews.com
Cell MedX (OTCMKTS:CMXC) Trading Down 7.7%
November 24, 2021 |  americanbankingnews.com
News for Cell MedX Corp
December 24, 2020 |  markets.businessinsider.com
Cell MedX Corp (CMXC)
October 20, 2020 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Industry
Conglomerates
Sub-Industry
N/A
Current Symbol
OTCMKTS:CMXC
Previous Symbol
NASDAQ:CMXC
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.88 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Cell MedX (OTCMKTS:CMXC) Frequently Asked Questions

How has Cell MedX's stock price been impacted by Coronavirus?

Cell MedX's stock was trading at $0.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CMXC shares have decreased by 45.5% and is now trading at $0.1690.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Cell MedX?

Cell MedX saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 6,100 shares, an increase of 1,933.3% from the October 31st total of 300 shares. Based on an average daily trading volume, of 45,200 shares, the short-interest ratio is presently 0.1 days.
View Cell MedX's Short Interest
.

Who are Cell MedX's key executives?

Cell MedX's management team includes the following people:
  • Frank E. Mcenulty, Chief Executive Officer & Director
  • Joao da Costa, Chief Operating Officer & Director
  • Yanika S. Silina, CFO, Secretary, Treasurer & Director
  • Bradley Hargreaves, Director, VP-Technology & Operations

What other stocks do shareholders of Cell MedX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cell MedX investors own include Callon Petroleum (CPE), Himax Technologies (HIMX), Remark (MARK), MicroVision (MVIS), Ritter Pharmaceuticals (RTTR), Linn Energy (LINEQ), AudioEye (AEYE), (ARMP), Bank of America (BAC) and Celldex Therapeutics (CLDX).

What is Cell MedX's stock symbol?

Cell MedX trades on the OTCMKTS under the ticker symbol "CMXC."

How do I buy shares of Cell MedX?

Shares of CMXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cell MedX's stock price today?

One share of CMXC stock can currently be purchased for approximately $0.17.

What is Cell MedX's official website?

The official website for Cell MedX is cellmedx.com.

Where are Cell MedX's headquarters?

How can I contact Cell MedX?

Cell MedX's mailing address is 123 W Nye Ln Ste 446, CARSON CITY, NV 89706-0899, United States. The company can be reached via phone at (844) 238-2692.


This page was last updated on 12/9/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.